IDIBELL researchers successfully test a new combination therapy in sarcomas

(IDIBELL-Bellvitge Biomedical Research Institute) Researchers of the Sarcoma group of the Oncobell program -- Bellvitge Biomedical Research Institute (IDIBELL) have successfully tested a new combined therapy for the treatment of this rare, aggressive tumor type, which affects children and adults.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news